Ganciclovir sodium and Post procedural complication - a phase IV clinical study of FDA data

Summary:

Post procedural complication is reported as a side effect among people who take Ganciclovir sodium (ganciclovir sodium), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Prednisone, and have Glioma.

The phase IV clinical study analyzes which people have Post procedural complication when taking Ganciclovir sodium. It is created by eHealthMe based on reports of 1,176 people who have side effects when taking Ganciclovir sodium from the FDA, and is updated regularly.

What is Ganciclovir sodium?

Ganciclovir sodium has active ingredients of ganciclovir sodium. eHealthMe is studying from 1,177 Ganciclovir sodium users. Check the latest studies of Ganciclovir sodium.

What is Post procedural complication?

Post procedural complication is found to be associated with 1,089 drugs and 1,362 conditions by eHealthMe. Check the latest studies of Post procedural complication.

On Jul, 11, 2026

1,176 people reported to have side effects when taking Ganciclovir sodium.
Among them, 23 people (1.96%) have Post procedural complication.

Could Ganciclovir sodium cause Post procedural complication?

Among these 23 people:

How long have people been on Ganciclovir sodium when they have Post procedural complication? *

What is the gender of people who have Post procedural complication when taking Ganciclovir sodium? *

female: 13.64 %
male: 86.36 %

What is the age of people who have Post procedural complication when taking Ganciclovir sodium? *

What are other drugs people take besides Ganciclovir sodium? *

Prednisone: 11 people, 47.83%
Prograf: 8 people, 34.78%
Omeprazole: 6 people, 26.09%
Cellcept: 4 people, 17.39%
Rapamune: 4 people, 17.39%
Prevacid: 4 people, 17.39%
Prednisolone: 3 people, 13.04%
Valcyte: 3 people, 13.04%
Vancomycin Hydrochloride: 3 people, 13.04%
Levothyroxine Sodium: 3 people, 13.04%

What are other side effects people have besides Post procedural complication? *

Haemoglobin Decreased: 6 people, 26.09%
Weight Decreased: 5 people, 21.74%
Coughing Up Blood: 5 people, 21.74%
Pleural Effusion (water on the lungs): 4 people, 17.39%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 4 people, 17.39%
Lung Infection: 3 people, 13.04%
Nausea (feeling of having an urge to vomit): 3 people, 13.04%
Catheter Related Infection: 3 people, 13.04%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 3 people, 13.04%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 13.04%

What are the existing conditions these people have? *

Glioma (a type of tumour that starts in the brain or spine): 4 people, 17.39%
Staphylococcal Bacteraemia (a bacterial infection of blood): 2 people, 8.70%
Immunodeficiency Disorders: 2 people, 8.70%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 4.35%
Liver Disorder (liver diseases): 1 person, 4.35%
Infection: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Ganciclovir sodium and have Post procedural complication?

- Check whether Post procedural complication is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ganciclovir sodium:

Ganciclovir sodium (1,177 reports)

Browse all side effects of Ganciclovir sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Post procedural complication:

Post procedural complication (1,089 drugs)

Browse all the conditions that are associated with Post procedural complication:

Post procedural complication (1,362 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ganciclovir sodium (the active ingredients of Ganciclovir sodium) and Ganciclovir sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.